AML cells have higher expression of METTL3 compared to HSPCs and a CRISPR dropout screen identified METTL3, METTL14, WTAP and KIAA1429 as essential for the survival of AML cells, indicating a potential oncogenic role for m6A modification in AML [36]. The gene discussed is METTL3; the disease is acute myeloid leukemia.